MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.

TL;DR: In this article , an overview of recent advances in the application of ionomics in metabolic disease research is provided, focusing on the studies about ionomic or multi-elemental profiling of different biological samples for several major types of metabolic diseases, such as diabetes mellitus, obesity, and metabolic syndrome, which reveal distinct and dynamic patterns of ion contents and their potential benefits in the detection and prognosis of these illnesses.

TL;DR: In this article, the authors investigated the mechanisms of high-fat diet (HFD) and cigarette smoking (CS) individually and in combination on the pathogenesis of NASH in mice.

TL;DR: Lee et al. as mentioned in this paper evaluated the association between FLI and incident type 2 diabetes and determined whether FLI could be used as an indicator of T2DM using a large-sample, community-based Korean cohort over 12 years.

TL;DR: This guidance provides a data-supported approach to the diagnostic, therapeutic, and preventive aspects of NAFLD care.

TL;DR: The large number of patients with NAFLD with potential for progressive liver disease creates challenges for screening, as the diagnosis of NASH necessitates invasive liver biopsy.

TL;DR: If current trends continue, the 2025 global physical activity target (a 10% relative reduction in insufficient physical activity) will not be met and policies to increase population levels of physical activity need to be prioritised and scaled up urgently.

TL;DR: The prevalence of hepatic steatosis was greater in men than women among whites, but not in blacks or Hispanics, and significant ethnic and sex differences in the prevalence may have a profound impact on susceptibility to Steatosis‐related liver disease.